ECM-alginate microcarriers for alveolar regeneration in COPD

Deniz Ali Bölükbas*, Zaid Rahman, Sinem Tas, Sandra Lindstedt, Han Gardeniers, Arturo Susarrey Arce, Darcy Wagner

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionAcademicpeer-review

Abstract

With 65 million patients globally, chronic obstructive pulmonary disease (COPD) is the third-leading cause of death. It is characterized by progressive and irreversible airflow limitation in the lung resulting from chronic airway inflammation and/or loss of alveolar tissue. Current treatments for COPD can only stop or slow down disease progression with no cure. The only option for end-stage disease is lung transplantation with restricted efficacy due to scarcity of donor lungs and high rejection rates. Hence, novel therapeutic strategies are urgently needed.

To address this, we aimed to develop alveolar type 2 (AT2) cell-bearing microcarriers derived from decellularized extracellular matrix (dECM) for alveolar regeneration in COPD lungs. Both AT2 cells and dECM have demonstrated regenerative effects in lung diseases in previous studies but were never reported for use in COPD therapy.

dECM was obtained with perfusion-based decellularization of murine, porcine, or human lungs followed by enzymatic digestion. Size-tunable monodispersed dECM-alginate microcarriers were formed in a custom-made microfluidic device.

The size of the microcarriers was directly dependent on the flow rate of alginate solution and dECM properties. Cell-bearing microcarriers with various alginate to dECM ratios could be generated ranging from sizes of 30 to 100 µm, which is in the range of individual mouse and human alveoli.

With our custom-built microfluidic chip, we are able to generate monodispersed dECM-alginate microcarriers which can be loaded with stem or progenitor cells. Microcarriers are versatile platforms that can support transplanted cells while providing healthy ECM in vivo, and thus has potential in COPD treatment.
Original languageEnglish
Title of host publicationERS International Congress 2020 abstracts
PublisherEuropean Respiratory Society
Number of pages1
Volume56
Edition64
DOIs
Publication statusE-pub ahead of print/First online - 28 Oct 2020

Publication series

NameEuropean Respiratory Journal
PublisherEuropean Respiratory Journal
ISSN (Print)0903-1936
ISSN (Electronic)1399-3003

Keywords

  • COPD
  • Experimental approaches
  • Epithelial cell

Fingerprint

Dive into the research topics of 'ECM-alginate microcarriers for alveolar regeneration in COPD'. Together they form a unique fingerprint.

Cite this